US4072565A
(en)
|
1974-11-04 |
1978-02-07 |
The Dow Chemical Company |
Production of viruses in tissue culture without use of serum
|
US3883511A
(en)
|
1974-03-07 |
1975-05-13 |
Rit Rech Ind Therapeut |
New 6-aminopenicillanic acid derivative
|
USRE30985E
(en)
|
1978-01-01 |
1982-06-29 |
|
Serum-free cell culture media
|
US4419446A
(en)
|
1980-12-31 |
1983-12-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant DNA process utilizing a papilloma virus DNA as a vector
|
NZ201705A
(en)
|
1981-08-31 |
1986-03-14 |
Genentech Inc |
Recombinant dna method for production of hepatitis b surface antigen in yeast
|
DE3271210D1
(en)
|
1981-12-24 |
1986-06-19 |
Asahi Chemical Ind |
Method for the cultivation of normal diploid cells and cultivation medium used therefor
|
US4601978A
(en)
|
1982-11-24 |
1986-07-22 |
The Regents Of The University Of California |
Mammalian metallothionein promoter system
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
FR2543158B1
(fr)
|
1983-03-24 |
1985-11-15 |
Inst Nat Sante Rech Med |
Milieu de culture de cellules animales sans serum, sans hormones et sans facteurs de croissance et procedes de culture primaire et d'obtention de lignees cellulaires utilisant ce milieu
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
US4965199A
(en)
|
1984-04-20 |
1990-10-23 |
Genentech, Inc. |
Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
|
US4879231A
(en)
|
1984-10-30 |
1989-11-07 |
Phillips Petroleum Company |
Transformation of yeasts of the genus pichia
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
GB8610600D0
(en)
|
1986-04-30 |
1986-06-04 |
Novo Industri As |
Transformation of trichoderma
|
IL87737A
(en)
|
1987-09-11 |
1993-08-18 |
Genentech Inc |
Method for culturing polypeptide factor dependent vertebrate recombinant cells
|
CA1338518C
(en)
|
1987-09-23 |
1996-08-13 |
Joyce M. Zarling |
Antibody heteroconjugates for the killing of hiv-infected cells
|
DE3801236A1
(de)
|
1988-01-18 |
1989-07-27 |
Boehringer Mannheim Gmbh |
Pentosansulfat-medium
|
DE68925971T2
(de)
|
1988-09-23 |
1996-09-05 |
Cetus Oncology Corp |
Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
|
US6048728A
(en)
|
1988-09-23 |
2000-04-11 |
Chiron Corporation |
Cell culture medium for enhanced cell growth, culture longevity, and product expression
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
KR0184860B1
(ko)
|
1988-11-11 |
1999-04-01 |
메디칼 리써어치 카운실 |
단일영역 리간드와 이를 포함하는 수용체 및 이들의 제조방법과 이용(법)
|
US5529920A
(en)
|
1988-12-14 |
1996-06-25 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Human liver epithelial cell line and culture media therefor
|
JPH03504330A
(ja)
|
1988-12-14 |
1991-09-26 |
アメリカ合衆国 |
ヒト肝上皮細胞系のための細胞培地
|
FR2646437B1
(fr)
|
1989-04-28 |
1991-08-30 |
Transgene Sa |
Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
DE69029036T2
(de)
|
1989-06-29 |
1997-05-22 |
Medarex Inc |
Bispezifische reagenzien für die aids-therapie
|
ATE194384T1
(de)
|
1989-09-12 |
2000-07-15 |
Hoffmann La Roche |
Tnf-bindende proteine
|
US5959177A
(en)
|
1989-10-27 |
1999-09-28 |
The Scripps Research Institute |
Transgenic plants expressing assembled secretory antibodies
|
JP2897043B2
(ja)
*
|
1989-12-21 |
1999-05-31 |
東ソー株式会社 |
完全合成培地
|
DE69120146T2
(de)
|
1990-01-12 |
1996-12-12 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
JP3230091B2
(ja)
|
1990-06-25 |
2001-11-19 |
ウェルファイド株式会社 |
ヒト血清アルブミンの着色抑制方法
|
ES2246502T3
(es)
|
1990-08-29 |
2006-02-16 |
Genpharm International, Inc. |
Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
EP0571390B1
(en)
|
1990-11-23 |
2000-03-08 |
Peptech Limited |
The delay, prevention and/or reversal of cell senescence
|
ES2113940T3
(es)
|
1990-12-03 |
1998-05-16 |
Genentech Inc |
Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas.
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
EP0586505A1
(en)
|
1991-05-14 |
1994-03-16 |
Repligen Corporation |
Heteroconjugate antibodies for treatment of hiv infection
|
US7018809B1
(en)
|
1991-09-19 |
2006-03-28 |
Genentech, Inc. |
Expression of functional antibody fragments
|
DK0605522T3
(da)
|
1991-09-23 |
2000-01-17 |
Medical Res Council |
Fremgangsmåde til fremstilling af humaniserede antistoffer
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
WO1993008829A1
(en)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions that mediate killing of hiv-infected cells
|
US5667988A
(en)
|
1992-01-27 |
1997-09-16 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
AU675929B2
(en)
|
1992-02-06 |
1997-02-27 |
Curis, Inc. |
Biosynthetic binding protein for cancer marker
|
WO1993018143A1
(en)
|
1992-03-04 |
1993-09-16 |
Synaptic Pharmaceutical Corporation |
Dna encoding taurine and gaba transporters and uses thereof
|
JPH07102147B2
(ja)
|
1992-03-16 |
1995-11-08 |
株式会社ミドリ十字 |
ヒト血清アルブミンの着色抑制方法
|
ATE149570T1
(de)
|
1992-08-17 |
1997-03-15 |
Genentech Inc |
Bispezifische immunoadhesine
|
CA2149329C
(en)
|
1992-11-13 |
2008-07-15 |
Darrell R. Anderson |
Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
|
US5426699A
(en)
|
1993-10-25 |
1995-06-20 |
Antec Corporation |
Method and apparatus for digitizing a scrambled analog video signal
|
EP0666312A1
(en)
|
1994-02-08 |
1995-08-09 |
Wolfgang A. Renner |
Process for the improvement of mammalian cell growth
|
US5856179A
(en)
|
1994-03-10 |
1999-01-05 |
Genentech, Inc. |
Polypeptide production in animal cell culture
|
US5789199A
(en)
|
1994-11-03 |
1998-08-04 |
Genentech, Inc. |
Process for bacterial production of polypeptides
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
US5840523A
(en)
|
1995-03-01 |
1998-11-24 |
Genetech, Inc. |
Methods and compositions for secretion of heterologous polypeptides
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
ES2304786T3
(es)
|
1995-04-27 |
2008-10-16 |
Amgen Fremont Inc. |
Anticuerpos anti-il-8 humanos, derivados a partir de xenoratones inmunizados.
|
EP0823941A4
(en)
|
1995-04-28 |
2001-09-19 |
Abgenix Inc |
HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
|
US5705364A
(en)
|
1995-06-06 |
1998-01-06 |
Genentech, Inc. |
Mammalian cell culture process
|
US6656466B1
(en)
|
1995-06-06 |
2003-12-02 |
Genetech, Inc. |
Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
|
CA2196802A1
(en)
|
1995-07-17 |
1997-02-06 |
Josef Wissler |
Metal-containing ribonucleotide polypeptides
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
JP4306813B2
(ja)
|
1995-09-19 |
2009-08-05 |
アスビオファーマ株式会社 |
動物細胞の新規培養方法
|
US6043092A
(en)
|
1996-03-18 |
2000-03-28 |
University Of Pittsburgh |
Cell culture media for mammalian cells
|
US6146847A
(en)
*
|
1996-11-01 |
2000-11-14 |
Genespan Corporation |
Stabilized transient gene expression
|
DK1500329T3
(da)
|
1996-12-03 |
2012-07-09 |
Amgen Fremont Inc |
Humane antistoffer, der specifikt binder TNF-alfa
|
US20080318254A9
(en)
|
1997-03-10 |
2008-12-25 |
The Regents Of The University Of California |
PSCA antibodies and hybridomas producing them
|
US20020012991A1
(en)
|
1997-04-07 |
2002-01-31 |
Florence Chua Nee Ho Kit Fong |
Cell culture media for enhanced protein production
|
US20020173629A1
(en)
|
1997-05-05 |
2002-11-21 |
Aya Jakobovits |
Human monoclonal antibodies to epidermal growth factor receptor
|
US6171586B1
(en)
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
WO1998059035A2
(en)
|
1997-06-25 |
1998-12-30 |
The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health |
Serum-free cell growth medium
|
US6610833B1
(en)
|
1997-11-24 |
2003-08-26 |
The Institute For Human Genetics And Biochemistry |
Monoclonal human natural antibodies
|
EP1045898A2
(en)
*
|
1998-01-12 |
2000-10-25 |
Betagene, Inc. |
Compositions and methods for regulated secretion from neuroendocrine cell lines
|
US6528286B1
(en)
|
1998-05-29 |
2003-03-04 |
Genentech, Inc. |
Mammalian cell culture process for producing glycoproteins
|
AU3877800A
(en)
|
1999-03-30 |
2000-10-16 |
Trustees Of Boston University |
Compositions and methods for producing platelets and/or proplatelets from megakaryocytes
|
DE60039596D1
(de)
|
1999-03-30 |
2008-09-04 |
Japan Tobacco Inc |
Verfahren zur herstellung von monoklonalen antikörpern
|
AT409379B
(de)
|
1999-06-02 |
2002-07-25 |
Baxter Ag |
Medium zur protein- und serumfreien kultivierung von zellen
|
IL146890A0
(en)
|
1999-06-08 |
2002-08-14 |
Regeneron Pharma |
Modified chimeric polypeptides with improved pharmacokinetic properties
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
CN1114619C
(zh)
|
1999-06-25 |
2003-07-16 |
中国科学院上海细胞生物学研究所 |
小鼠杂交瘤株Hepama-1分泌的肝癌鼠源单克隆抗体的制备方法
|
AU782626B2
(en)
|
1999-10-04 |
2005-08-18 |
Medicago Inc. |
Method for regulating transcription of foreign genes
|
US7125978B1
(en)
|
1999-10-04 |
2006-10-24 |
Medicago Inc. |
Promoter for regulating expression of foreign genes
|
US7105348B2
(en)
|
2000-10-31 |
2006-09-12 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
RU2192884C2
(ru)
|
2000-11-09 |
2002-11-20 |
Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН |
Вакцина для стимуляции противоопухолевого иммунитета
|
US7311905B2
(en)
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
US20090137416A1
(en)
|
2001-01-16 |
2009-05-28 |
Regeneron Pharmaceuticals, Inc. |
Isolating Cells Expressing Secreted Proteins
|
JP4323167B2
(ja)
|
2001-01-16 |
2009-09-02 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
分泌タンパク質を発現する細胞の単離
|
WO2002092017A2
(en)
|
2001-05-16 |
2002-11-21 |
Albert Einstein College Of Medicine Of Yeshiva University |
Human antipneumococcal antibodies from non-human animals
|
AU2002316230A1
(en)
|
2001-06-13 |
2002-12-23 |
Genentech, Inc. |
Methods of culturing animal cells and polypeptide production in animal cells
|
JP4359503B2
(ja)
|
2001-08-23 |
2009-11-04 |
ゲンマブ エー/エス |
インターロイキン15(il−15)に特異的なヒト抗体
|
EP1321515A1
(en)
|
2001-12-21 |
2003-06-25 |
Ingenium Pharmaceuticals AG |
Method of culturing cells
|
CN1180080C
(zh)
|
2002-01-18 |
2004-12-15 |
中国科学院上海细胞生物学研究所 |
一种改进的肝癌鼠源单克隆抗体的制备方法
|
SG106672A1
(en)
|
2002-03-08 |
2004-10-29 |
Asml Netherlands Bv |
Mask for use in lithography, method of making a mask, lithographic apparatus, and device manufacturing method
|
US20030190710A1
(en)
*
|
2002-03-28 |
2003-10-09 |
Devries Ruth L. |
Control of glycoforms in IgG
|
JP4817657B2
(ja)
|
2002-05-29 |
2011-11-16 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
誘導性の真核生物発現システム
|
US8673589B2
(en)
|
2002-05-29 |
2014-03-18 |
Regeneron Pharmaceuticals, Inc. |
Inducible eukaryotic expression system
|
US7371922B2
(en)
|
2002-07-31 |
2008-05-13 |
The Board Of Trustees Of The University Of Illinois |
Nuclear transfer with porcine embryonic stem cells
|
US6924124B1
(en)
|
2002-08-23 |
2005-08-02 |
Immunex Corporation |
Feeding strategies for cell culture
|
CA2513308A1
(en)
|
2003-01-17 |
2004-08-05 |
Josef Michl |
Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
|
WO2004069172A2
(en)
|
2003-01-30 |
2004-08-19 |
The Government of the United States of America as represented by the Department of Veterans Affairs |
Multilineage-inducible cells and uses thereof
|
ATE472597T2
(de)
|
2003-05-15 |
2010-07-15 |
Wyeth Llc |
Kontrollierte glukosezufuhr für tierzellkultur
|
AU2004270103B2
(en)
|
2003-05-21 |
2012-02-23 |
E. R. Squibb & Sons, L.L.C. |
Human monoclonal antibodies against Bacillusanthracis protective antigen
|
US7303694B2
(en)
|
2003-07-17 |
2007-12-04 |
Wisconsin Alumni Research Foundation |
Liquid crystals with reduced toxicity and applications thereof
|
MXPA06003028A
(es)
|
2003-09-18 |
2006-06-23 |
Raven Biotechnologies Inc |
Medios de cultivo de celulas.
|
WO2005121176A1
(fr)
|
2004-06-08 |
2005-12-22 |
Chengdu Kanghong Biotechnologies Co. Ltd |
Proteine chimerique inhibitrice d'angiogenese et utilisation associee
|
TWI384069B
(zh)
|
2004-08-27 |
2013-02-01 |
Pfizer Ireland Pharmaceuticals |
多胜肽之製法
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
WO2006050050A2
(en)
*
|
2004-10-29 |
2006-05-11 |
Centocor, Inc. |
Chemically defined media compositions
|
US20060094104A1
(en)
|
2004-10-29 |
2006-05-04 |
Leopold Grillberger |
Animal protein-free media for cultivation of cells
|
US8273553B2
(en)
|
2004-11-02 |
2012-09-25 |
Ares Trading S.A. |
Production of growth hormone in serum-free cell culture medium for mammalian cells
|
US8207303B2
(en)
|
2005-02-18 |
2012-06-26 |
Medarex, Inc. |
Monoclonal antibodies against CD30 lacking in fucosyl residues
|
JP2008536524A
(ja)
|
2005-04-21 |
2008-09-11 |
グレン エー. ゴールドスタイン, |
不妊に関連する酸化ストレス治療のためのn−アセチルシステインアミド(nacアミド)
|
KR20070122497A
(ko)
|
2005-04-22 |
2007-12-31 |
제넨테크, 인크. |
Cd20 항체로 치매 또는 알츠하이머병을 치료하는 방법
|
PE20070796A1
(es)
|
2005-10-24 |
2007-08-15 |
Wyeth Corp |
Metodo de produccion proteica utilizando compuestos anti-senescencia
|
RU2486236C2
(ru)
|
2006-01-04 |
2013-06-27 |
Бакстер Интернэшнл Инк. |
Способ экспрессии белка
|
EP1818392B1
(en)
|
2006-02-14 |
2010-08-25 |
Genetix Limited |
Cell culture medium
|
US8216575B2
(en)
|
2006-03-31 |
2012-07-10 |
Chengdu Kanghong Biotechnologies Co., Ltd. |
Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains
|
MX2008014804A
(es)
|
2006-06-02 |
2009-01-27 |
Regeneron Pharma |
Anticuerpos de afinidad elevada a receptor de il-6 humano.
|
CA2654716A1
(en)
|
2006-06-09 |
2007-12-21 |
Anthrogenesis Corporation |
Placental niche and use thereof to culture stem cells
|
US7534595B2
(en)
*
|
2006-06-12 |
2009-05-19 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
|
US7608693B2
(en)
|
2006-10-02 |
2009-10-27 |
Regeneron Pharmaceuticals, Inc. |
High affinity human antibodies to human IL-4 receptor
|
CA2668771C
(en)
|
2006-11-08 |
2016-03-15 |
Wyeth |
Rationally designed media for cell culture
|
TW200902708A
(en)
|
2007-04-23 |
2009-01-16 |
Wyeth Corp |
Methods of protein production using anti-senescence compounds
|
DK2150617T3
(en)
|
2007-06-04 |
2015-01-12 |
Regeneron Pharma |
Regions with increased expression and stability
|
US20100221823A1
(en)
|
2007-06-11 |
2010-09-02 |
Amgen Inc. |
Method for culturing mammalian cells to improve recombinant protein production
|
PL2178916T3
(pl)
|
2007-07-31 |
2015-08-31 |
Regeneron Pharma |
Ludzkie przeciwciała przeciwko ludzkiemu CD20 i sposób ich zastosowania
|
ES2591284T3
(es)
|
2007-08-07 |
2016-11-25 |
Chugai Seiyaku Kabushiki Kaisha |
Método para la producción de proteínas heterogéneas
|
US8309088B2
(en)
|
2007-08-10 |
2012-11-13 |
Regeneron Pharmaceuticals, Inc. |
Method of treating osteoarthritis with an antibody to NGF
|
CN100482786C
(zh)
|
2007-12-28 |
2009-04-29 |
天津百若克医药生物技术有限责任公司 |
一种人胚肾293细胞扩增无蛋白培养基
|
US8637312B2
(en)
|
2008-01-09 |
2014-01-28 |
Cellca Gmbh |
Mammalian culture media with polyamine and iron
|
CN102224239A
(zh)
|
2008-09-26 |
2011-10-19 |
先灵公司 |
高效价抗体生产
|
JO3672B1
(ar)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
|
CA2764370C
(en)
|
2009-06-02 |
2018-08-21 |
Regeneron Pharmaceuticals, Inc. |
Fucosylation-deficient cells
|
CN101603026B
(zh)
*
|
2009-06-19 |
2011-01-19 |
华东理工大学 |
适于动物细胞产品生产的无动物来源低蛋白培养基
|
AU2010265933B2
(en)
|
2009-06-26 |
2015-05-14 |
Regeneron Pharmaceuticals, Inc. |
Readily isolated bispecific antibodies with native immunoglobulin format
|
CA2765220A1
(en)
|
2009-07-14 |
2011-01-20 |
Biogen Idec Ma Inc. |
Methods for inhibiting yellow color and peroxide formation in a composition
|
KR101756354B1
(ko)
|
2009-07-31 |
2017-07-26 |
백스터 인터내셔널 인코포레이티드 |
Adamts 단백질 발현을 위한 세포 배양 배지
|
HUE048980T2
(hu)
|
2009-08-11 |
2020-08-28 |
Hoffmann La Roche |
Fehérjék elõállítása glutaminmentes sejttenyésztõ táptalajban
|
ES2776980T3
(es)
|
2009-12-23 |
2020-08-03 |
Merck Sharp & Dohme |
Línea celular 3M
|
JO3417B1
(ar)
|
2010-01-08 |
2019-10-20 |
Regeneron Pharma |
الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
|
JO3340B1
(ar)
|
2010-05-26 |
2019-03-13 |
Regeneron Pharma |
مضادات حيوية لـعامل تمايز النمو 8 البشري
|
PL2591094T3
(pl)
|
2010-07-08 |
2019-02-28 |
Baxalta GmbH |
Sposób otrzymywania rekombinowanego adamts13 w linii komórkowej
|
JOP20190250A1
(ar)
|
2010-07-14 |
2017-06-16 |
Regeneron Pharma |
صيغ مستقرة تحتوي على الأجسام المضادة لمضاد عامل نمو الأعصاب
|
JP2013536683A
(ja)
|
2010-08-31 |
2013-09-26 |
フリエスランド ブランズ ビー.ブイ. |
真核細胞のための培養培地
|
AR083044A1
(es)
|
2010-09-27 |
2013-01-30 |
Regeneron Pharma |
Anticuerpos anti-cd48 y usos de los mismos
|
NZ609557A
(en)
|
2010-10-06 |
2014-12-24 |
Regeneron Pharma |
Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
|
KR20130118899A
(ko)
|
2010-11-05 |
2013-10-30 |
애브비 인코포레이티드 |
세포배양에서의 화학적으로 규명된 배지의 개발을 위한 효율적이고 효과적인 보충물 스크리닝
|
JO3756B1
(ar)
|
2010-11-23 |
2021-01-31 |
Regeneron Pharma |
اجسام مضادة بشرية لمستقبلات الجلوكاجون
|
CN102093978A
(zh)
|
2010-12-17 |
2011-06-15 |
上海市农业科学院 |
猪早期胚胎发育前期培养液及后期培养液
|
SG191371A1
(en)
|
2010-12-28 |
2013-08-30 |
Chugai Pharmaceutical Co Ltd |
Animal cell culturing method
|
US20120171161A1
(en)
|
2010-12-30 |
2012-07-05 |
Sascha Abramson |
Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
|
JO3412B1
(ar)
|
2011-06-17 |
2019-10-20 |
Regeneron Pharma |
أجسام مضادة ل angptl3 واستخداماتها
|
CN108771655A
(zh)
*
|
2011-10-28 |
2018-11-09 |
诚信生物公司 |
含有氨基酸的蛋白质制剂
|
ES2663946T3
(es)
|
2011-11-14 |
2018-04-17 |
Regeneron Pharmaceuticals, Inc. |
Composiciones y métodos para aumentar la masa y la fuerza muscular antagonizando específicamente GDF8 y/o Activina A
|
SG11201403792TA
(en)
|
2012-01-23 |
2014-10-30 |
Regeneron Pharma |
Stabilized formulations containing anti-ang2 antibodies
|
WO2013120497A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
JP6090735B2
(ja)
|
2012-03-02 |
2017-03-08 |
国立大学法人山口大学 |
消化器系がん幹細胞を培養するための無血清培地、及びそれを用いた消化器系がん幹細胞の増殖方法
|
US9181572B2
(en)
|
2012-04-20 |
2015-11-10 |
Abbvie, Inc. |
Methods to modulate lysine variant distribution
|
US9150645B2
(en)
|
2012-04-20 |
2015-10-06 |
Abbvie, Inc. |
Cell culture methods to reduce acidic species
|
CA2875294C
(en)
|
2012-04-25 |
2021-06-08 |
Riken |
Cell preparation containing myocardium-committed cell
|
JO3820B1
(ar)
|
2012-05-03 |
2021-01-31 |
Regeneron Pharma |
أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها
|
EP2882846B1
(en)
|
2012-06-05 |
2018-09-05 |
The Regents of the University of California |
Methods and compositions for the rapid production of retinal pigmented epithelial cells from pluripotent cells
|
CN104640969A
(zh)
|
2012-06-21 |
2015-05-20 |
巴克斯特国际公司 |
细胞培养基的病毒过滤
|
TW201843172A
(zh)
|
2012-06-25 |
2018-12-16 |
美商再生元醫藥公司 |
抗-egfr抗體及其用途
|
SG11201500480TA
(en)
|
2012-08-02 |
2015-02-27 |
Sanofi Sa |
Article of manufacture comprising aflibercept or ziv-aflibercept
|
WO2014028354A1
(en)
|
2012-08-13 |
2014-02-20 |
Regeneron Pharmaceuticals, Inc. |
Anti-pcsk9 antibodies with ph-dependent binding characteristics
|
WO2014029772A1
(en)
|
2012-08-20 |
2014-02-27 |
Schreder |
Method of and system for isolating led luminaires from electrical surges
|
JOP20200236A1
(ar)
|
2012-09-21 |
2017-06-16 |
Regeneron Pharma |
الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
|
CN104718291B
(zh)
|
2012-10-10 |
2020-12-01 |
中外制药株式会社 |
经修饰的宿主细胞的建立方法
|
JO3405B1
(ar)
|
2013-01-09 |
2019-10-20 |
Regeneron Pharma |
الأجسام المضادة لمضاد مستقبل عامل النمو المشتق من الصفائح الدموية - بيتا واستخداماتها
|
US9173380B2
(en)
|
2013-02-18 |
2015-11-03 |
Garmin Switzerland Gmbh |
Animal indicator apparatus
|
JO3532B1
(ar)
|
2013-03-13 |
2020-07-05 |
Regeneron Pharma |
الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
|
TWI659968B
(zh)
|
2013-03-14 |
2019-05-21 |
再生元醫藥公司 |
針對呼吸道融合病毒f蛋白質的人類抗體及其使用方法
|
US9217168B2
(en)
|
2013-03-14 |
2015-12-22 |
Momenta Pharmaceuticals, Inc. |
Methods of cell culture
|
WO2014145098A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Genentech, Inc. |
Cell culture compositions with antioxidants and methods for polypeptide production
|
US20160237400A1
(en)
|
2013-03-15 |
2016-08-18 |
The Jackson Laboratory |
Isolation of non-embryonic stem cells and uses thereof
|
AR095196A1
(es)
|
2013-03-15 |
2015-09-30 |
Regeneron Pharma |
Medio de cultivo celular libre de suero
|
EA034834B1
(ru)
|
2013-03-15 |
2020-03-26 |
Ридженерон Фармасьютикалз, Инк. |
Антагонисты il-33 и их применение
|
WO2014191240A1
(en)
|
2013-05-29 |
2014-12-04 |
F. Hoffmann-La Roche Ag |
Quantitative control of sialylation
|
JP6108170B2
(ja)
|
2013-07-30 |
2017-04-05 |
株式会社大阪ソーダ |
細胞培養用培地
|
TWI641620B
(zh)
|
2013-08-21 |
2018-11-21 |
再生元醫藥公司 |
抗-prlr抗體及其用途
|
EP3791862A1
(en)
*
|
2013-09-11 |
2021-03-17 |
Eagle Biologics, Inc. |
Liquid protein formulations containing viscosity-lowering agents
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
JP2017502922A
(ja)
|
2013-10-29 |
2017-01-26 |
アルブミディクス アクティーゼルスカブ |
抗体組成物
|
MX2016009084A
(es)
|
2014-01-13 |
2016-10-13 |
Amgen Inc |
Regulacion del metabolismo de ornitina para manipular el contenido de glicoformas ricas en manosa de proteinas recombinantes.
|
TWI681969B
(zh)
|
2014-01-23 |
2020-01-11 |
美商再生元醫藥公司 |
針對pd-1的人類抗體
|
TWI680138B
(zh)
|
2014-01-23 |
2019-12-21 |
美商再生元醫藥公司 |
抗pd-l1之人類抗體
|
PL3126388T3
(pl)
|
2014-03-11 |
2019-10-31 |
Regeneron Pharma |
Przeciwciała anty-egfrviii i ich zastosowania
|
TWI701042B
(zh)
|
2014-03-19 |
2020-08-11 |
美商再生元醫藥公司 |
用於腫瘤治療之方法及抗體組成物
|
CA3225091A1
(en)
|
2014-05-05 |
2015-11-12 |
Regeneron Pharmaceuticals, Inc. |
Humanized c5 and c3 animals
|
JO3701B1
(ar)
|
2014-05-23 |
2021-01-31 |
Regeneron Pharma |
مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي
|
MA40021A
(fr)
|
2014-06-03 |
2015-12-10 |
Lupin Ltd |
Processus de culture cellulaire destiné à produire une protéine
|
SG11201701711VA
(en)
|
2014-09-16 |
2017-04-27 |
Regeneron Pharma |
Anti-glucagon antibodies and uses thereof
|
TWI710573B
(zh)
|
2015-01-26 |
2020-11-21 |
美商再生元醫藥公司 |
抗伊波拉病毒醣蛋白之人類抗體
|
CA3208857A1
(en)
|
2015-04-01 |
2016-10-06 |
Boehringer Ingelheim International Gmbh |
Cell culture medium
|
TWI797060B
(zh)
|
2015-08-04 |
2023-04-01 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
IL258036B
(en)
|
2015-09-23 |
2022-09-01 |
Regeneron Pharma |
Optimized bispecific antibodies against class 3 determinants and their uses
|
KR101936049B1
(ko)
|
2015-10-15 |
2019-01-08 |
(주)알테오젠 |
IgG Fc 도메인을 가지는 융합 단백질의 생산방법
|
TWI734775B
(zh)
|
2016-04-26 |
2021-08-01 |
美商美國泰福生技股份有限公司 |
細胞培養基
|
KR20210084695A
(ko)
|
2017-07-06 |
2021-07-07 |
리제너론 파마슈티칼스 인코포레이티드 |
당단백질을 만들기 위한 세포 배양 과정
|